Amygdalin is a candidate compound for COVID-19 treatment by regulating IL6, SRC, MAPK1 EGFR and VEGFA to involve in PI3K-Akt signaling pathway, VEGF signaling pathway and MAPK signaling pathway. The gene discussed is VEGFA; the disease is COVID-19.